Sarah Rybowski
About Sarah Rybowski
Sarah Rybowski serves as the VP of Global Medical Strategy, Scientific Communications and Publications at Insmed Incorporated, bringing extensive experience from her previous roles at Bayer Pharmaceuticals and Eli Lilly and Company. She is recognized for her leadership in medical affairs and her commitment to operational excellence and strategic planning in the healthcare sector.
Current Role at Insmed
Sarah Rybowski serves as the Vice President of Global Medical Strategy, Scientific Communications, and Publications at Insmed Incorporated. She has been in this role since 2024, working in Bridgewater, New Jersey. In her position, she focuses on developing and executing medical strategies that align with the company's objectives. Her responsibilities include overseeing scientific communications and managing publications to support the company's initiatives.
Previous Experience at Bayer Pharmaceuticals
Sarah Rybowski held multiple roles at Bayer Pharmaceuticals from 2010 to 2019. She began as a Global Medical Affairs Physician in Berlin, Germany, before transitioning to New Jersey. Her roles included Global Women's Healthcare Lead and Senior Global Medical Affairs Physician from 2011 to 2015, Global Medical Director & Strategic Lead for Hematology from 2015 to 2016, and Global Real World Evidence Strategy Lead for Oncology from 2016 to 2019. Throughout her tenure, she contributed to the development of operational excellence within medical affairs teams.
Experience at Eli Lilly and Company
Sarah Rybowski worked at Eli Lilly and Company from 2019 to 2024. She served as the US Medical Lead for Global Medical Affairs in Oncology for two years and then as the Head of Global/US Medical Affairs for the Oncology Breast franchise for three years. In these roles, she focused on strategic planning and the implementation of initiatives to enhance medical affairs operations.
Education and Qualifications
Sarah Rybowski studied at Godolphin and Latymer before pursuing higher education at Imperial College London. She achieved her MBBS with honors and holds qualifications in DFFP and MRCGP (Dist). Her educational background supports her expertise in medical affairs and strategic planning within the pharmaceutical industry.
Expertise in Medical Affairs
Sarah Rybowski specializes in establishing and executing strategies for external research opportunities, including industry-sponsored and investigator-initiated trials. She has a proven track record in creating and implementing infrastructure to drive efficiency in product launches. Her strong focus on promotional material review and capability building enhances her effectiveness in medical strategy.